ArticleJournal of experimental & clinical cancer research : CR2025

STARD4 suppresses tumorigenesis and attenuates enzalutamide resistance via lipid metabolic reprogramming and AR stabilization in prostate cancer.

Yi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.